Low frequency of HBsAg reemergence in liver transplant recipients after stopping hepatitis B immune globulin: Implications for prophylaxis protocols

Liver Transpl. 2024 Jun 1;30(6):668-671. doi: 10.1097/LVT.0000000000000311. Epub 2023 Dec 12.

Authors

Mimi Xu¹, Collin T Mayemura¹, Niwen Kong¹, Yuri S Genyk², Jeffrey A Kahn¹, Norah A Terrault¹

Affiliations

¹ Division of Gastrointestinal and Liver Diseases, University of Southern California, Los Angeles, California, USA.
² Division of Hepatobiliary/Pancreatic and Abdominal Organ Transplant Surgery, University of Southern California, Los Angeles, California, USA.

PMID: 38079257
DOI: 10.1097/LVT.0000000000000311

No abstract available

Publication types

Letter

MeSH terms

Adult
Antiviral Agents / therapeutic use
Female
Hepatitis B Surface Antigens* / blood
Hepatitis B Surface Antigens* / immunology
Hepatitis B virus* / immunology
Hepatitis B* / epidemiology
Hepatitis B* / immunology
Hepatitis B* / prevention & control
Humans
Immunoglobulins* / administration & dosage
Immunoglobulins* / therapeutic use
Liver Transplantation* / adverse effects
Male
Middle Aged
Retrospective Studies

Substances

hepatitis B hyperimmune globulin